TRNS Transcat Inc

  1. Stocks
  2. Industrials
  3. NASDAQ: TRNS

Price (delayed)

$109.84

Market cap

$969.79M

P/E Ratio

82.59

Dividend/share

N/A

EPS

$1.33

Enterprise value

$953.77M

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly ...

Highlights
The equity has soared by 129% YoY and by 58% from the previous quarter
The debt has plunged by 72% from the previous quarter and by 69% YoY
The price to earnings (P/E) is 82% higher than the 5-year quarterly average of 45.3 and 15% higher than the last 4 quarters average of 71.7
Sector: Industrials
Industry: Industrial Distribution
Website: http://www.transcat.com
Peers: DHR COHU A EMR

Key stats

What are the main financial stats of TRNS
Market
Shares outstanding
8.83M
Market cap
$969.79M
Enterprise value
$953.77M
Valuations
Price to earnings (P/E)
82.59
Price to book (P/B)
4.44
Price to sales (P/S)
3.78
EV/EBIT
57.84
EV/EBITDA
32.84
EV/Sales
3.81
Earnings
Revenue
$250.64M
EBIT
$16.49M
EBITDA
$29.04M
Free cash flow
$18.5M
Per share
EPS
$1.33
Free cash flow per share
$2.15
Book value per share
$24.75
Revenue per share
$29.09
TBVPS
$17.87
Balance sheet
Total assets
$281.07M
Total liabilities
$62.6M
Debt
$19.18M
Equity
$218.47M
Working capital
$69.45M
Liquidity
Debt to equity
0.09
Current ratio
3.37
Quick ratio
2.7
Net debt/EBITDA
-0.55
Margins
EBITDA margin
11.6%
Gross margin
31.5%
Net margin
4.2%
Operating margin
6.6%
Efficiency
Return on assets
4.5%
Return on equity
7.3%
Return on invested capital
11.8%
Return on capital employed
6.6%
Return on sales
6.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TRNS stock price

How has the Transcat stock price performed over time
Intraday
-1.29%
1 week
4.36%
1 month
-2.11%
1 year
38.9%
YTD
0.47%
QTD
-1.43%

Financial performance

How have Transcat's revenue and profit performed over time
Revenue
$250.64M
Gross profit
$78.92M
Operating income
$16.43M
Net income
$10.42M
Gross margin
31.5%
Net margin
4.2%
Transcat's gross profit has increased by 20% YoY and by 6% QoQ
The net income has grown by 20% from the previous quarter and by 3.3% YoY
The net margin has grown by 17% from the previous quarter but it has contracted by 7% YoY
Transcat's revenue has increased by 12% YoY and by 3.2% from the previous quarter

Growth

What is Transcat's growth rate over time

Valuation

What is Transcat stock price valuation
TRNS P/E details
P/E
82.59
P/B
4.44
P/S
3.78
EV/EBIT
57.84
EV/EBITDA
32.84
EV/Sales
3.81
The price to earnings (P/E) is 82% higher than the 5-year quarterly average of 45.3 and 15% higher than the last 4 quarters average of 71.7
The EPS is up by 16% since the previous quarter
The equity has soared by 129% YoY and by 58% from the previous quarter
TRNS's price to book (P/B) is 21% lower than its last 4 quarters average of 5.6 and 8% lower than its 5-year quarterly average of 4.8
The P/S is 72% above the 5-year quarterly average of 2.2 and 22% above the last 4 quarters average of 3.1
Transcat's revenue has increased by 12% YoY and by 3.2% from the previous quarter

Efficiency

How efficient is Transcat business performance
TRNS's ROE is down by 34% year-on-year and by 6% since the previous quarter
Transcat's return on assets has decreased by 18% YoY but it has increased by 10% QoQ
The company's return on invested capital rose by 16% QoQ and by 10% YoY
The ROS is up by 6% since the previous quarter

Dividends

What is TRNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TRNS.

Financial health

How did Transcat financials performed over time
The quick ratio has soared by 71% YoY and by 65% from the previous quarter
TRNS's total assets is up by 49% YoY and by 13% from the previous quarter
The debt is 91% less than the equity
The equity has soared by 129% YoY and by 58% from the previous quarter
Transcat's debt to equity has shrunk by 86% YoY and by 82% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.